Literature DB >> 31558560

Treatment for depression comorbid with dementia.

Nina Baruch1, Jennifer Burgess2,3, Manjunadh Pillai2, Charlotte Louise Allan4,3.   

Abstract

Depression is a common comorbidity in dementia. Randomised controlled studies of antidepressants do not show a significant improvement in depressive symptoms in patients with comorbid dementia and are known to lead to an increase in side effects. However, there are relatively few studies of depression in dementia, and drawing firm conclusions about the use of antidepressants is limited by the amount of data available. Furthermore, it is unclear whether data can be extrapolated from similar populations (eg, those with late-life depression) to inform pharmacotherapy in this patient group. Given the lack of effectiveness and risk of side effects associated with pharmacological treatments, psychological interventions may offer important therapeutic benefits. There is evidence for the effectiveness of individual psychological therapy, and further research will establish which psychological approach is the most effective. Some studies have shown an improvement in depressive symptoms using structured sleep hygiene programmes, exercise, arts interventions and music therapy. These studies are hampered by small data sets, and the benefits to individuals may not be well captured by standard outcome measures. At present, the best evidence for arts-based approaches is in music therapy. Depression with comorbid dementia responds well to electroconvulsive therapy and this is a useful treatment modality for those with severe or life-threatening depressive symptoms. Alternative neurostimulation techniques such as transcranial magnetic stimulation are not widely used at present and further research is needed before they can be a more widely used treatment modality. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  delirium & cognitive disorders; depression & mood disorders

Year:  2019        PMID: 31558560     DOI: 10.1136/ebmental-2019-300113

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


  4 in total

1.  Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Olaia Martínez-Iglesias; Lola Corzo; Natalia Cacabelos; Rocío Pego; Juan C Carril
Journal:  Methods Mol Biol       Date:  2022

2.  Exercise Ameliorates Fluoride-induced Anxiety- and Depression-like Behavior in Mice: Role of GABA.

Authors:  Qiqi Cao; Jixiang Wang; Yanru Hao; Fangye Zhao; Rong Fu; Yanghuan Yu; Jundong Wang; Ruiyan Niu; Shengtai Bian; Zilong Sun
Journal:  Biol Trace Elem Res       Date:  2021-04-06       Impact factor: 3.738

3.  Psychiatric comorbid disorders of cognition: a machine learning approach using 1175 UK Biobank participants.

Authors:  Chenlu Li; Delia A Gheorghe; John E Gallacher; Sarah Bauermeister
Journal:  Evid Based Ment Health       Date:  2020-07-29

Review 4.  Personalized Management and Treatment of Alzheimer's Disease.

Authors:  Ramón Cacabelos; Vinogran Naidoo; Olaia Martínez-Iglesias; Lola Corzo; Natalia Cacabelos; Rocío Pego; Juan C Carril
Journal:  Life (Basel)       Date:  2022-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.